▶주메뉴 바로가기
▶본문 바로가기
[THE INVESTOR] L&C Bio, a tissue engineering company, said on Aug. 31 it has gained preliminary approval for its initial public offering on Korea‘s secondary bourse KOSDAQ. The company plans to flo...
[THE INVESTOR] Celltrion Healthcare , the marketing unit of biosimilar developer Celltrion , posted a 47 percent dip in first-half operating profit, hit by increased competition and lower selling...
[THE INVESTOR] Medytox said on Aug. 29 that it has filed a biologics license application with the Taiwan Food and Drug Administration for the sale of its botulinum toxin Neuronox. The news sent its ...
[THE INVESTOR] Celltrion said on Aug. 29 it has wrapped up phase 3 clinical trials for a subcutaneous formulation of its anti-inflammatory therapy Remsima, and will seek marketing approval in Europ...
[THE INVESTOR] Bukwang Pharmaceutical has secured over 80 billion won (US$72.13 million) through its investments in biotechnology companies. The investment return is 10 times bigger than its opera...
[THE INVESTOR] Daewoong Pharmaceutical Chairman Yoon Jae-seung said on Aug. 27 he will step down from all positions in the company following news reports of his abusive behavior against employees. ...
[THE INVESTOR ] Shares of JW Pharmaceutical rose over 5 percent on Aug. 27 as the Korean drug maker has signed a license agreement with Denmark-based LEO Pharma for its atopic dermatitis therapy i...
[THE INVESTOR] Korean medical device companies are establishing their presence and rapidly increasing their footprint in China, a huge market that is rapidly facing an aging society with rising medi...
[THE INVESTOR] Korean pharmaceutical company Dong-A ST said on Aug. 23 it has bought the license for an oncolytic virus therapy from a Japanese biotech firm Takara Bio to expand its anti-cancer dr...
[THE INVESTOR] Bridge Biotherapeutics, a clinical stage biotech company, said on Aug. 23 it will seek approval from the US Food and Drug Administration to begin human clinical trials of BBT-877, its...
[THE INVESTOR] T&R Biofab said on Aug. 22 it has signed an original equipment manufacturing agreement with German pharma firm Merck to supply its bio ink that allows 3D printing of complex living ti...
[THE INVESTOR] GC Pharma, a Korean pharmaceutical company, said on Aug. 22 it has set up a local company in Brazil to make further inroads into the South American market. GC Pharma invested 534 mill...
[THE INVESTOR] YD Global Life Science said on Aug. 21 it has received approval from the US Food and Drug Administration to initiate phase 2a clinical trials of YD-312, its drug candidate to treat di...
[THE INVESTOR] ToolGen, Korea’s biotech specialized in genome editing, is expected to be the first biotech firm to be listed on the secondary KOSDAQ under the so-called “Tesla standards,” a relaxed ...
[THE INVESTOR] Daewoong Pharmaceutical said on Aug. 20 it has received marketing approval from Canadian health authorities in less than a year after it applied for one for its botulinum toxin Nabot...
L-Tree applies biometric technology to blockchain
Market Kurly operator secures W67b investment
Samsung's cooktops get high scores from U.S. Consumer Report
Two Samsung Group affiliates sell stake in Samsung C&T
KT ties up with firm behind Apple’s Siri for car infotainment systems
Samsung unveils triple-lens smartphone Galaxy A7
Parliament passes bill easing regulations on internet-only banks
Hanon Systems to acquire Magna’s fluid pressure and controls biz
September 26, 2018
